<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Basic Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Basic Med Sci</journal-id><journal-title-group><journal-title>Iranian Journal of Basic Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">2008-3866</issn><issn pub-type="epub">2008-3874</issn><publisher><publisher-name>Mashhad University of Medical Sciences</publisher-name><publisher-loc>Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29796225</article-id><article-id pub-id-type="pmc">5960758</article-id><article-id pub-id-type="publisher-id">IJBMS-21-404</article-id><article-id pub-id-type="doi">10.22038/IJBMS.2018.27510.6714</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The protective effects of naringin against 5-fluorouracil-induced hepatotoxicity and nephrotoxicity in rats</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gelen</surname><given-names>Volkan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>&#x0015e;eng&#x000fc;l</surname><given-names>Emin</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Y&#x00131;ld&#x00131;r&#x00131;m</surname><given-names>Serkan</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Atila</surname><given-names>G&#x000f6;zde</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Physiology, Veterinary Faculty, Kafkas University, Kars, Turkey</aff><aff id="aff2"><label>2</label>Department of Physiology, Veterinary Faculty, Ataturk University, Erzurum, Turkey</aff><aff id="aff3"><label>3</label>Department of Pathology, Veterinary Faculty, Ataturk University, Erzurum, Turkey</aff><author-notes><corresp id="cor1"><label>*</label><italic>Corresponding author:</italic> Volkan Gelen. Department of Physiology, Veterinary Faculty, Kafkas University, Kars, Turkey. Email: <email xlink:href="gelen_volkan@hotmail.com">gelen_volkan@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2018</year></pub-date><volume>21</volume><issue>4</issue><fpage>404</fpage><lpage>410</lpage><history><date date-type="received"><day>09</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>28</day><month>9</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Iranian Journal of Basic Medical Sciences</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Objective(s):</title><p>5-fluorouracil-induced (5-FU), an anticarcinogenic agent, is reported to have side-effects that include hepatotoxicity and nephrotoxicity. The study objective was to investigate the protective effects of naringin on 5-FU-induced hepatotoxicity and nephrotoxicity.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>Thirty rodents were assigned to three groups. The control group received 1 ml of intragastric distilled water for 14 days. The 5-FU group received 1 ml of distilled water for 14 days as a placebo. On day 9, this same group received a 20 mg/kg dose of 5-FU administered intraperitoneally(IP) for a further five days. The naringin+5-FU group received a 100 mg/kg dose of naringin (IP) for 14 days. On day 9, 20 mg/kg of 5-FU was administered (IP) to this group for a further five days. On day 15, the rats were decapitated, and blood and renal and hepatic tissues were taken.</p></sec><sec id="st3"><title>Results:</title><p>It was determined that serum creatinine, BUN, AST, ALT, ALP, and LDH levels, as well as cytokine levels in the liver and kidney tissues were significantly elevated in the 5-FU group, compared to the control group. The comparative values were similar in the control and naringin+5-FU groups. When the liver tissue was examined histopathologically, in the control group it was found to be normal in structure. However, necrosis was observed in the hepatocytes of the pericentric region in the 5-FU group. 8-OHdG cell density was significantly elevated in the 5-FU group, compared to the control and naringin+5-FU groups.</p></sec><sec id="st4"><title>Conclusion:</title><p>Naringin was observed to have a protective effect on 5-FU-induced liver and kidney damage.</p></sec></abstract><kwd-group><kwd>5-fluorouracil</kwd><kwd>Hepatotoxicity</kwd><kwd>Naringin</kwd><kwd>Nephrotoxicity</kwd><kwd>Rat</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>5-fluorouracil (5-FU), a fluorinated pyrimidine, is classified as an antimetabolic agent and influences the synthesis of DNA and RNA in normal and tumor cells. The majority of 5-FU is abolished through liver metabolism and only a small portion is removed from the body via kidney excretion. 5-FU is widely used in chemotherapy for various cancers (<xref rid="ref1" ref-type="bibr">1</xref>). As a fluoropyrimidine antimetabolite agent, it plays an important role in the treatment of colon, breast, gastrointestinal, head, neck, and pancreatic cancer (<xref rid="ref1" ref-type="bibr">1</xref>). However, serious toxicity and unwanted side-effects occur following its use (<xref rid="ref2" ref-type="bibr">2</xref>) and it is considered to be a nephrotoxic compound (<xref rid="ref3" ref-type="bibr">3</xref>). In addition, it has hepatotoxic effects, with increased aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and alkaline phosphatase (ALP) activity in tissue (<xref rid="ref4" ref-type="bibr">4</xref>, <xref rid="ref5" ref-type="bibr">5</xref>).</p><p>A number of studies have been conducted on the use of natural therapies to avoid the side-effects of anticancer agents (<xref rid="ref6" ref-type="bibr">6</xref>-<xref rid="ref10" ref-type="bibr">10</xref>). Naringin is a flavonoid that is usually found in grapefruit, orange and cooked tomato paste (<xref rid="ref11" ref-type="bibr">11</xref>). It has antioxidant, immunomodulatory and anti-inflammatory properties. Flavonoids may have a protective effect against disease through various mechanisms, i.e., by activating and protecting antioxidant enzymes in the cells (<xref rid="ref12" ref-type="bibr">12</xref>) or reacting directly or indirectly to reactive oxygen species (ROS) via the transfer of hydrogen atoms (<xref rid="ref13" ref-type="bibr">13</xref>). Naringin was reported in various studies to be protective against hepatotoxicity and nephrotoxicity (<xref rid="ref14" ref-type="bibr">14</xref>, <xref rid="ref15" ref-type="bibr">15</xref>).</p><p>The objective of the current study was to evaluate the hepatoprotective and nephroprotective potential of naringin against 5-FU-induced liver and renal toxicity.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><p>Thirty male adult Sprague-Dawley rats, weighing 220&#x02013;250 g, were included in the study. The animals were housed under adequate moisture and light conditions, at a suitable room temperature, and were provided with sufficient water and food until the day of the experiment. The study was performed in accordance with the national guidelines on the use and care of laboratory animals and was approved by the Animal Experiments&#x02019; Ethics Committee of Kafkas University.</p><p>The rats were divided into three groups (<xref ref-type="table" rid="T1">Table 1</xref>), consisting of a control and two experimental groups. The control group received 1 ml intragastric distilled water for 14 days. The 5-FU group received 1 ml of distilled water for 14 days as a placebo. On day 9, this same group received a 20 mg/kg dose of 5-FU that was administered (IP) for a further five days. The naringin +5-FU group received a 100 mg/kg dose of naringin (dissolved in water oil) for 14 days. On day 9, 20 mg/kg 5-FU was administered (IP) to this group for a further five days.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>All groups of study and animal protocols</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Groups</th><th align="center" rowspan="1" colspan="1">Treatment</th><th align="center" rowspan="1" colspan="1">number of animals in groups</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Control</td><td align="center" rowspan="1" colspan="1">Control (distilled water)</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">5-FU</td><td align="center" rowspan="1" colspan="1">5-FU (20 mg/kg IP)</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Naringin+ 5-FU</td><td align="center" rowspan="1" colspan="1">100 mg/kg naringin + 5-FU (20 mg/kg IP)</td><td align="center" rowspan="1" colspan="1">10</td></tr></tbody></table></table-wrap><p>On day 15, the rats were anesthetized, intracardiac</p><p>blood samples were taken and the animals were sacrificed. Blood, kidney, and liver tissue samples were collected for biochemical analysis to determine the cytokine parameters (interleukin [IL]-1&#x003b1;, tumor necrosis factor-alpha [TNF-&#x003b1;], and IL-6). A histopathological examination was conducted.</p><sec id="sec2-1"><title>Blood sample collection</title><p>Five days after taking the 5-FU treatment (i.e., on day 15), blood samples were separately collected from the liver and kidneys of each rat. Thereafter, the rodents were euthanized via cervical dislocation. The blood samples were centrifuged at 1,500 g for 12 min within 1 hr of collection to obtain serum samples, which were immediately analyzed.</p></sec><sec id="sec2-2"><title>Oxidative parameters</title><p>The hepatic and renal tissues were homogenized using TissueLyzer II<sup>&#x000ae;</sup> (Qiagen, Germantown, USA). The homogenates were centrifuged at 10,000 g for 20 min at 4 &#x000b0;C and supernatants were obtained. Superoxide dismutase (SOD) activity was assessed and thiobarbituric acid reactive substance and glutathione (GSH) levels were determined (<xref rid="ref16" ref-type="bibr">16</xref>).</p></sec><sec id="sec2-3"><title>Biochemical cytokine analysis</title><p>Rat-specific cytokine levels were established for IL-6, TNF-&#x003b1;, and IL-1&#x003b1; using an immunoassay kit (Elabscience Biotechnology Co., Ltd, USA), according to manufacturer&#x02019;s instructions. The results were expressed as mean&#x000b1;standard deviation (SD) (pg/ml or ng/ml).</p></sec><sec id="sec2-4"><title>Histopathological and immunohistochemical study</title><p>The liver and kidney tissue samples were collected, placed in a 10% formalin solution for 48 hr and then washed under running tap water for histopathological evaluation. The tissue was routinely processed and was then buried in blocks of paraffin. Tissue sections cut to 4 &#x003bc;m thickness were taken from each block, placed on the slides, stained and examined under a Leica DM 1000 Laboratory Microscope (Leica Microsystems, Buffalo Grove, USA) to perform an accurate assessment of the hematoxylin-eosin and fibrous tissue staining and adhesion. 8-hydroxy-2&#x02019; -deoxyguanosine (8-OhdG) staining was conducted with respect to hepatic and renal immunohistochemistry. 8-OhdG-positive cell intensity was scored as none = -; weak = +; moderate = ++ and strong = +++.</p></sec><sec id="sec2-5"><title>Statistical analysis</title><p>All data were statistically evaluated by one-way ANOVA using SPSS 20.00, followed by Duncan <italic>post hoc</italic> test. The data were expressed as mean &#x000b1; SD. <italic>P&#x0003c;</italic>0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><sec id="sec2-6"><title>Effect of naringin on liver and renal weight in g/kg body weight</title><p>The weight of the liver and kidneys (g/kg of body weight) in the 5-FU-treated animals was shown to be significantly increased compared to the control group (<italic>P&#x0003c;</italic>0.050). By contrast, that in the 100-mg naringin-treated group was observed to be significantly decreased when compared to the 5-FU group (<italic>P&#x0003c;</italic>0.050). The liver and kidney weight measurements, expressed as g/kg of body weight, are outlined in <xref ref-type="table" rid="T2">Table 2</xref>.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Weight of organ in g/kg body weight in the experimental groups (<italic>P&#x0003c;</italic>0.05, n=10) the results are expressed as mean&#x000b1;SD</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">weight of liver in g/kg body weight</th><th align="center" rowspan="1" colspan="1">renal weight in g/kg body weight</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Control</td><td align="center" rowspan="1" colspan="1">0.44<sup>a</sup> &#x000b1; 0.01</td><td align="center" rowspan="1" colspan="1">0.08<sup>a</sup> &#x000b1; 0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">5-FU</td><td align="center" rowspan="1" colspan="1">0.52<sup>b</sup> &#x000b1; 0.02</td><td align="center" rowspan="1" colspan="1">0.11<sup>b</sup> &#x000b1; 0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">Naringin+5-FU</td><td align="center" rowspan="1" colspan="1">0.39<sup>a</sup> &#x000b1; 0.03</td><td align="center" rowspan="1" colspan="1">0.07<sup>a</sup> &#x000b1; 0.002</td></tr></tbody></table></table-wrap></sec><sec id="sec2-7"><title>Liver and renal tissues SOD activity, GSH and TBARS levels</title><p>The SOD activity and the GSH levels of the 5-FU-treated animals were markedly reduced compared with the control group (<italic>P&#x0003c;</italic>0.050). However, the GSH levels in the 100-mg naringin-treated group were significantly elevated compared to those in the 5-FU group <italic>(P&#x0003c;</italic>0.050). The GSH levels that were determined for all groups are shown in Figures <xref ref-type="fig" rid="F1">1 A</xref> and <xref ref-type="fig" rid="F1">B</xref> and Figures <xref ref-type="fig" rid="F2">2 A</xref> and <xref ref-type="fig" rid="F2">B</xref>.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Illustration of levels of oxidative parameters (SOD, GSH, and TBARS) for all groups in the liver tissues. A; SOD activity, B; GSH activity, and C; TBARS levels, the letters indicate the statistical differences among groups (<italic>P&#x0003c;</italic>0.05, n=10), the results were expressed as mean&#x000b1;SD</p></caption><graphic xlink:href="IJBMS-21-404-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Illustration of levels of oxidative parameters (SOD, GSH, and TBARS) for all groups in the renal tissues. A; SOD activity, B; GSH activity, and C; TBARS levels, the letters indicate the statistical differences among groups (P&#x0003c;0.05, n=10), the results were expressed as mean&#x000b1;SD</p></caption><graphic xlink:href="IJBMS-21-404-g002"/></fig><p>Thiobarbituric acid reactive substance (TBARS) levels were higher in the 5-FU group than in the other groups (<italic>P&#x0003c;</italic>0.050). However, treatment with a naringin dose of 100 mg greatly inhibited the increase in TBARS levels (<italic>P&#x0003c;</italic>0.050). The data collected on TBARS levels for all groups are presented in Figures <xref ref-type="fig" rid="F1">1 C</xref> and <xref ref-type="fig" rid="F2">2 C</xref>.</p></sec><sec id="sec2-8"><title>Effect of naringin on liver marker enzymes (ALT, AST, and ALP)</title><p>The liver enzyme activities in the 5-FU-treated animals were shown to be significantly increased when compared to the control group (<italic>P&#x0003c;</italic>0.050). An inverse result was found for the 100-mg naringin-treated group when compared to the 5-FU group (<italic>P&#x0003c;</italic>0.050). The liver enzyme activity in all groups is depicted in Figures <xref ref-type="fig" rid="F3">3 A</xref>, <xref ref-type="fig" rid="F3">B</xref>, and <xref ref-type="fig" rid="F3">C</xref>.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Illustration of serum liver and kidney parameters for all groups. A; AST, B; ALT; C; ALP, D; LDH, E; BUN, and F; Creatine, the letters indicate the statistical differences among groups (<italic>P&#x0003c;</italic>0.05, n=10), the results were expressed as mean&#x000b1;SD</p></caption><graphic xlink:href="IJBMS-21-404-g003"/></fig></sec><sec id="sec2-9"><title>Effect of naringin on renal markers (LDH, BUN, and Creatinine)</title><p>The LDH, blood urea nitrogen (BUN), and creatinine levels of the 5-FU-treated animals were greatly elevated, compared to the control group (<italic>P&#x0003c;</italic>0.050). By contrast, the BUN and creatinine levels in the 100-mg naringin-treated group were significantly decreased in the 5-FU group (<italic>P&#x0003c;</italic>0.050). The data on the LDH, BUN, and creatinine levels for all the groups are shown in Figures <xref ref-type="fig" rid="F3">3 D</xref>, <xref ref-type="fig" rid="F3">E</xref>, and <xref ref-type="fig" rid="F3">F</xref>.</p></sec><sec id="sec2-10"><title>Biochemical cytokine (IL-6, IL-1&#x003b1;, and TNF-&#x003b1;) levels in the liver and renal tissues</title><p>Following cytokine analysis, the IL-6 levels were shown to be greatly higher in the 5-FU group than in the other groups (<italic>P&#x0003c;</italic>0.050) (<xref ref-type="fig" rid="F4">Figure 4 A</xref>). A statistically significant difference between the control and naringin +5-FU groups in this regard was also observed (<italic>P&#x0003c;</italic>0.050). A marked difference was also applicable to the IL-1&#x003b1; and TNF-&#x003b1; levels in the 5-FU group, when compared to the other groups (<italic>P&#x0003c;</italic>0.050). A statistically significant difference was not found between the control and the naringin+5-FU groups in this regard (<italic>P&#x0003c;</italic>0.050) (Figures <xref ref-type="fig" rid="F4">4 B</xref> and <xref ref-type="fig" rid="F4">C</xref>).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Biochemical cytokine levels in the liver tissues for all groups. A; IL-6, B; IL-1&#x003b1;; C; TNF-&#x003b1;, the letters indicate the statistical differences among groups (<italic>P&#x0003c;</italic>0.05, n=10), the results were expressed as mean&#x000b1;SD</p></caption><graphic xlink:href="IJBMS-21-404-g004"/></fig><p>Similarly, IL-6, IL-1&#x003b1;, and TNF-&#x003b1; levels were significantly higher in the 5-FU group than in the other groups (<italic>P&#x0003c;</italic>0.050). A statistically significant difference between the control and naringin+5-FU groups was reported (<italic>P&#x0003c;</italic>0.050) (Figures <xref ref-type="fig" rid="F5">5 A</xref>, <xref ref-type="fig" rid="F5">B</xref>, and <xref ref-type="fig" rid="F5">C</xref>).</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>Biochemical cytokine levels in the kidney tissues for all groups. A; IL-6, B; IL-1&#x003b1;; C; TNF-&#x003b1;, the letters indicate the statistical differences among groups (<italic>P&#x0003c;</italic>0.05, n=10), the results were expressed as mean&#x000b1;SD</p></caption><graphic xlink:href="IJBMS-21-404-g005"/></fig></sec><sec id="sec2-11"><title>Histopathological examination</title><p>Following liver and kidney tissue analysis, normal structure and histology were determined in the control group. Hydropic degeneration and coagulative necrosis were observed in the hepatocytes in the psoriasis region, and mononuclear cell infiltration in the portal region, in the 5-FU group, when the liver tissue was examined.</p><p>Following a kidney tissue assessment, tubular dilation, glomerular atrophy, dilatation of the Bowman&#x02019;s capsule, and degeneration and/or necrosis of the renal tubular epithelial cells were identified in the 5-FU group. However, following liver tissue analysis, necrotic cells were not identified when hydropic degeneration of the hepatocytes was observed in the pericentric region in the naringin+5-FU group. Mild hydropic degeneration was detected in the tubular epithelium cells when the kidney tissue was examined in the naringin+5-FU group (Figures <xref ref-type="fig" rid="F6 F7">6(A, B, C)</xref>, <xref ref-type="fig" rid="F8">8(A, B, C)</xref> and <xref ref-type="table" rid="T3">Table 3</xref>, <xref ref-type="table" rid="T4">4</xref>).</p><fig id="F6" position="float"><label>Figure 6</label><caption><p>Histopathologic examinations of rat liver sections of control (A), 5-FU (B), naringin 100+ 5-FU (C), H&#x00026;E, Bar:20 &#x000b5;m</p></caption><graphic xlink:href="IJBMS-21-404-g006"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><p>Immunohistochemical staining for 8-OHdG in the liver sections of control (A), 5-FU (B), and naringin +5-FU (C) groups, IHC, Bar: 20 &#x000b5;m</p></caption><graphic xlink:href="IJBMS-21-404-g007"/></fig><fig id="F8" position="float"><label>Figure 8</label><caption><p>Histopathologic examinations of rat renal sections of control (A), 5-FU (B), naringin 100+ 5-FU (C), H&#x00026;E, Bar:20 &#x000b5;m</p></caption><graphic xlink:href="IJBMS-21-404-g008"/></fig><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Histopathological evaluation of liver tissues</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Control</th><th align="center" rowspan="1" colspan="1">5-FU</th><th align="center" rowspan="1" colspan="1">Naringin + 5-FU</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Degeneration in hepatocytes</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">++</td></tr><tr><td align="left" rowspan="1" colspan="1">Necrosis in hepatocytes</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">+</td></tr><tr><td align="left" rowspan="1" colspan="1">Dilatation and hyperemia in sinusoids</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">++</td><td align="center" rowspan="1" colspan="1">+</td></tr><tr><td align="left" rowspan="1" colspan="1">8-OHdG</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">++</td></tr></tbody></table><table-wrap-foot><fn><p>Scored as: none = -; weak = +; moderate = ++; strong = +++</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Histopathological evaluation of renal tissue</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Control</th><th align="center" rowspan="1" colspan="1">5-FU</th><th align="center" rowspan="1" colspan="1">Naringin + 5-FU</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Degeneration in tubul epithelium</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">++</td></tr><tr><td align="left" rowspan="1" colspan="1">Necrosis in tubul epithelium</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">+</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyperemia</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">+</td></tr><tr><td align="left" rowspan="1" colspan="1">8-OHdG</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">++</td></tr></tbody></table><table-wrap-foot><fn><p>Scored as follows: none = -; weak = +; moderate = ++; strong = +++</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-12"><title>Immuno-histochemical findings</title><p>8-OHdG immunopositive reactions, with the use of 8-OHdG antibodies, were assessed in the liver and kidneys in all groups. 8-OHdG cell density was significantly elevated in the 5-FU group when compared with the control and naringin+5-FU groups (Figures <xref ref-type="fig" rid="F7">7</xref>-<xref ref-type="fig" rid="F9">9</xref>).</p><fig id="F9" position="float"><label>Figure 9</label><caption><p>Immunohistochemical staining for 8-OHdG in the renal sections of control (A), 5-FU (B) and naringin +5-FU (C) groups, IHC, Bar: 20 &#x000b5;m</p></caption><graphic xlink:href="IJBMS-21-404-g009"/></fig></sec></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>A widely used chemotherapeutic agent, 5-FU, has proven efficacy in human malignancy. However, its clinical utility is inhibited by hepatotoxic and nephrotoxic side-effects (<xref rid="ref17" ref-type="bibr">17</xref>,<xref rid="ref18" ref-type="bibr">18</xref>). ROS are produced when electrons from different systems penetrate oxygen in a living organism. The cellular antioxidant enzymatic and nonenzymatic defense plays a crucial role in alleviating tissue damage caused by free radicals (<xref rid="ref19" ref-type="bibr">19</xref>-<xref rid="ref21" ref-type="bibr">21</xref>). ROS has a direct effect on various biological components. It causes cellular damage and necrosis in the liver, kidney and other tissues (<xref rid="ref22" ref-type="bibr">22</xref>-<xref rid="ref25" ref-type="bibr">25</xref>).</p><p>The antioxidant defense system is the primary protective mechanism used to prevent cell damage to ROS. ROS damage increases portal and systemic endotoxin levels and translocation to the liver, resulting in ingestion by neutrophils and the release of ROS at higher levels (<xref rid="ref26" ref-type="bibr">26</xref>-<xref rid="ref28" ref-type="bibr">28</xref>). The elimination of ROS in normal healthy cells is accomplished by a radical scavenging system, comprising catalase (CAT), superoxide dismutase (SOD), and reduced GSH (<xref rid="ref29" ref-type="bibr">29</xref>). Oxidative stress can occur as a consequence of increased ROS production or a reduced antioxidant defense (<xref rid="ref30" ref-type="bibr">30</xref>, <xref rid="ref31" ref-type="bibr">31</xref>).</p><p>An increased amount of ROS has been reported in liver hepatic and renal toxicity induced by 5-FU (<xref rid="ref32" ref-type="bibr">32</xref>). It has been shown that antioxidants protect against 5-FU-induced hepatic and renal damage in rats. A reduction in the activity of significant antioxidant enzymes in the kidneys and liver, including SOD, CAT, and GSH, was also demonstrated following treatment with 5-FU (<xref rid="ref33" ref-type="bibr">33</xref>), as was an increase in serum malondialdehyde levels due to 5-FU-induced hepatotoxicity and nephrotoxicity.</p><p>In the current study lipid peroxidation was determined by measuring TBARS levels in rodent liver and kidney tissues. TBARS levels were higher in the 5-FU group than in the other groups, thereby explaining accelerated peroxidation levels in the liver and kidneys. SOD activity and GSH concentrations were significantly decreased in the hepatic and renal tissue following treatment with 5-FU. In contrast, a marked increase in SOD activity and GSH levels were detected when naringin was given to this group. The findings suggest that 5-FU-induced hepatotoxicity and nephrotoxicity arises from ROS, which disrupts the antioxidant system. It is thought that naringin prevents damage due to its antioxidant properties. This result is consistent with that reported in a previous study (<xref rid="ref33" ref-type="bibr">33</xref>).</p><p>Treatment with 5-FU resulted in a significant increase in serum ALT, AST, and ALP activities in the animals, in whom severe hepatotoxicity was established. These data are consistent with those reported elsewhere(<xref rid="ref34" ref-type="bibr">34</xref>). Excessive oxidative production and the accumulation of oxidation products in the liver damaged the biological membranes and the endothelial lining of the liver in the current study. This was probably due to liver damage, causing elevated ALT, AST, and ALP concentrations in the blood. ALT, AST, and ALP are considered to be the most important biological markers of cellular damage and toxicity (<xref rid="ref35" ref-type="bibr">35</xref>). A significant elevation in serum AST, ALT, and ALP activity has been used as an indicator of acute liver injury in other studies (<xref rid="ref36" ref-type="bibr">36</xref>, <xref rid="ref37" ref-type="bibr">37</xref>).</p><p>ALT is a cytosolic enzyme that targets the liver rather than other tissues, and AST is found in the mitochondria and targets the liver, skeletal muscles, and kidneys. ALP activity increases due to obstruction and inflammation of the biliary tract. To a great extent, its increase in the blood occurs when ALT and AST infiltrate the hepatocytes. This is considered to be a marker of liver damage or dysfunction. The administration of naringin resulted in the considerable recovery of and a significant reduction in the activity of these enzymes, suggestive of hepatotoxicity in animals exposed to 5-FU.</p><p>LDH, BUN, and creatinine are commonly used as markers in the analysis of kidney injury (<xref rid="ref38" ref-type="bibr">38</xref>). High BUN and serum creatinine levels indicate 5-FU-induced kidney damage. The results of the current study were consistent with the findings of previous studies (<xref rid="ref32" ref-type="bibr">32</xref>). Lower LDH, BUN, and serum creatinine levels, when compared with the 5-FU treated group, were found in rats to whom naringin had been administered. A reduction in LDH, BUN, and creatinine levels is possibly caused by the nephroprotective efficacy of naringin. A significant increase in LDH was seen in the 5-FU group, compared to the other groups (<xref rid="ref32" ref-type="bibr">32</xref>). However, the present findings revealed that naringin treatment significantly attenuated LDH, demonstrating that it has the potential to prevent renal damage.</p><p>The role of proinflammatory cytokines in the pathogenesis of hepatic and renal toxicity in relation to the cellular signaling pathways is still being researched. Cytokine secretion is the mediator of inflammation and contributes to the pathogenesis of tissue injury (<xref rid="ref39" ref-type="bibr">39</xref>, <xref rid="ref40" ref-type="bibr">40</xref>). It has been reported that proinflammatory cytokines are associated with a significant increase in serum IL-1&#x000df;, TNF-&#x003b1;, and IL-6 levels following 5-FU treatment in rats (<xref rid="ref41" ref-type="bibr">41</xref>).</p><p>The inhibitory effect of flavonoids in the release of chemical mediators, including IL-1&#x003b1;, TNF-&#x003b1;, and IL-6, was also reported (<xref rid="ref42" ref-type="bibr">42</xref>). Previous studies reported the inhibitory effect of naringin on IL-1&#x003b1;, TNF-&#x003b1;, and IL-6 (<xref rid="ref43" ref-type="bibr">43</xref>). In the current study, 5-FU treatment markedly increased IL-1&#x003b1;, TNF-&#x003b1; and IL-6 levels. Conversely, naringin treatment caused a significant reduction in IL-1&#x003b1;, TNF-&#x003b1;, and IL-6 levels in 5-FU-induced experimental rats. This is possibly owing to its anti-inflammatory properties. In the light of these findings, it can be deduced that naringin prevents kidney and liver inflammation caused by 5-FU.</p><p>Histopathological examination of liver and renal tissues in the 5-FU- treated group suggested cell injuries and necrosis in the liver and renal tissues. In previous studies degeneration and coagulative necrosis were observed in the hepatocytes and mononuclear cell infiltration in the portal region (<xref rid="ref4" ref-type="bibr">4</xref>, <xref rid="ref44" ref-type="bibr">44</xref>). Kidney tissue assessment, degeneration, and/or necrosis of the renal tubular epithelial cells were identified due to 5-FU administration (<xref rid="ref44" ref-type="bibr">44</xref>). Thus, the results of the present study revealed that naringin treatment resulted in minimal liver and renal damage and no necrosis in the liver and kidneys of 5-FU-induced rats.</p><p>8-OHdG is considered to be the most important indicator of DNA damage (<xref rid="ref45" ref-type="bibr">45</xref>, <xref rid="ref46" ref-type="bibr">46</xref>). Hydroxyl radicals destroy the hydrogenation of nucleic acid or react with double bonds, leading to 8-OHdG (<xref rid="ref47" ref-type="bibr">47</xref>). El-Sayyad <italic>et al</italic>. suggested that DNA damage intensified in rat testes following the administration of 5-FU (<xref rid="ref48" ref-type="bibr">48</xref>). 8-OHdG was shown to be a good indicator of tissue damage following 5-FU-induced nephrotoxicity in experimental rats in the current study. It has been reported elsewhere that DNA damage was diminished following the administration of antioxidants (<xref rid="ref49" ref-type="bibr">49</xref>). This supports the current study finding that naringin had an antioxidant effect, thereby reducing ROS-mediated 8-OHdG levels and preventing oxidative DNA damage. This suggests that naringin treatment has an important restorative effect on renal and hepatic injury induced by 5-FU.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>Naringin treatment can mitigate renal and hepatic damage caused by 5-FU-induced renal and hepatic toxicity in rats. Naringin also enhances the restoration of biochemical oxidative enzymes as it has anti-inflammatory, antioxidant, and DNA-protective properties. It was found in the current study that naringin was protective against 5-FU-induced renal and hepatic toxicity. Further studies are warranted to investigate its future clinical applications.</p></sec></body><back><ack><title>Acknowledgment</title><p>The authors thank the staff of the Veterinary Physiology Department of Kafkas University, Kars, Turkey, due to laboratory support.</p></ack><sec id="sec1-6"><title>Conflicts of interest</title><p>The authors declare no conflicts of interest.</p></sec><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longley</surname><given-names>DB</given-names></name><name><surname>Harkin</surname><given-names>DP</given-names></name><name><surname>Johnston</surname><given-names>PG</given-names></name></person-group><article-title>5- Fluorouracil: mechanisms of action and clinical strategies</article-title><source>Nat Rev Cancer</source><year>2003</year><volume>3</volume><fpage>330</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">12724731</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabellos</surname><given-names>R</given-names></name><name><surname>Garcia-Carbonero</surname><given-names>R</given-names></name><name><surname>Garcia-Lacalle</surname><given-names>C</given-names></name><name><surname>Gomez</surname><given-names>P</given-names></name><name><surname>Tercero</surname><given-names>A</given-names></name><name><surname>Sanchez</surname><given-names>D</given-names></name><etal/></person-group><article-title>Fluorouracil-based chemotherapy in patients with gastrointestinal malignancies: influence of nutritional folate status on toxicity</article-title><source>J Chemother</source><year>2007</year><volume>19</volume><fpage>744</fpage><lpage>749</lpage><pub-id pub-id-type="pmid">18230560</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaka</surname><given-names>Y</given-names></name><name><surname>Rakugi</surname><given-names>H</given-names></name></person-group><article-title>Severe adverse effects of 5-fluorouracil in S-1 were lessened by haemodialysis due to elimination of the drug, NDT</article-title><source>Plus Advance Access</source><year>2009</year><volume>18</volume><fpage>152</fpage><lpage>154</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelen</surname><given-names>V</given-names></name><name><surname>&#x0015e;eng&#x000fc;l</surname><given-names>E</given-names></name><name><surname>Gedikli</surname><given-names>S</given-names></name><name><surname>Atila</surname><given-names>G</given-names></name><name><surname>Uslu</surname><given-names>H</given-names></name><name><surname>Makav</surname><given-names>M</given-names></name></person-group><article-title>The protective effect of rutin and quercetin on 5-FU-induced hepatotoxicity in rats</article-title><source>Asian Pac J Trop Biomed</source><year>2017</year><volume>7</volume><fpage>647</fpage><lpage>653</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>S</given-names></name><name><surname>Roy</surname><given-names>K</given-names></name><name><surname>Sengupta</surname><given-names>C</given-names></name></person-group><article-title>In vitro evaluation of protective effects of ascorbic acid and water extract of Spirulina plantesis (blue green algae) on 5-fluorouracil-induced lipid peroxidation</article-title><source>Acta Pol Pharm</source><year>2007</year><volume>64</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">17665848</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x0015e;eng&#x000fc;l</surname><given-names>E</given-names></name><name><surname>Gelen</surname><given-names>V</given-names></name><name><surname>Gedikli</surname><given-names>S</given-names></name><name><surname>&#x000d6;zkanlar</surname><given-names>S</given-names></name><name><surname>G&#x000fc;r</surname><given-names>S</given-names></name><name><surname>&#x000c7;elebi</surname><given-names>F</given-names></name><etal/></person-group><article-title>The protective effect of quercetin on cyclophosphamide-Induced lung toxicity in rats</article-title><source>Biomed Pharmacother</source><year>2017</year><volume>92</volume><fpage>303</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">28551551</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JAS</given-names></name><name><surname>Piao</surname><given-names>YJ</given-names></name><name><surname>Kang</surname><given-names>KW</given-names></name></person-group><article-title>Effect of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and Pgp inhibition by quercetin</article-title><source>Arch Pharm Res</source><year>2011</year><volume>34</volume><fpage>607</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">21544726</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swamy</surname><given-names>AH</given-names></name><name><surname>Patel</surname><given-names>UM</given-names></name><name><surname>Koti</surname><given-names>BC</given-names></name><name><surname>Gadad</surname><given-names>PC</given-names></name><name><surname>Patel</surname><given-names>NL</given-names></name><name><surname>Thippeswamy</surname><given-names>AH</given-names></name></person-group><article-title>Cardioprotective effect of Saracaindicavagainst cyclophosphamide induced cardio toxicity in rats: a biochemical, electrocardiographic and histopathological study</article-title><source>Indian J Pharmacol</source><year>2013</year><volume>45</volume><fpage>48</fpage><lpage>56</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raskovic</surname><given-names>A</given-names></name><name><surname>Stilinovic</surname><given-names>N</given-names></name><name><surname>Kolarovic</surname><given-names>J</given-names></name><name><surname>Vasovic</surname><given-names>V</given-names></name><name><surname>Vukmirovic</surname><given-names>S</given-names></name><name><surname>Mikov</surname><given-names>M</given-names></name></person-group><article-title>The Protective Effects of Silymarin against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rat</article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>8601</fpage><lpage>8614</lpage><pub-id pub-id-type="pmid">21993249</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matouk</surname><given-names>AI</given-names></name><name><surname>Taye</surname><given-names>A</given-names></name><name><surname>Heeba</surname><given-names>GH</given-names></name><name><surname>El-Moselhy</surname><given-names>MA</given-names></name></person-group><article-title>Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats</article-title><source>Environ Toxicol Pharmacol</source><year>2013</year><volume>36</volume><fpage>443</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">23770454</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igual</surname><given-names>M</given-names></name><name><surname>Garcia-Martinez</surname><given-names>E</given-names></name><name><surname>Camacho</surname><given-names>MM</given-names></name><name><surname>Martinez-Navarrete</surname><given-names>N</given-names></name></person-group><article-title>Jam processing and storage effects on &#x003b2;-carotene and flavonoids content in grapefruit</article-title><source>J Funct Foods</source><year>2013</year><volume>5</volume><fpage>736</fpage><lpage>744</lpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Or&#x00161;oli&#x00107;</surname><given-names>N</given-names></name><name><surname>Gajski</surname><given-names>G</given-names></name><name><surname>Garaj-Vrhovac</surname><given-names>V</given-names></name><name><surname>&#x00110;iki&#x00107;</surname><given-names>D</given-names></name><name><surname>Prskalo</surname><given-names>ZS</given-names></name><name><surname>Sirovina</surname><given-names>D</given-names></name></person-group><article-title>DNA-protective effects of quercetin or naringin in alloxan-induced diabetic mice</article-title><source>Eur J Pharmacol</source><year>2011</year><volume>10</volume><fpage>110</fpage><lpage>118</lpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leopoldini</surname><given-names>M</given-names></name><name><surname>Russo</surname><given-names>N</given-names></name><name><surname>Toscano</surname><given-names>M</given-names></name></person-group><article-title>The molecular basis of working mechanism of natural polyphenolic antioxidants</article-title><source>Food Chem</source><year>2011</year><volume>125</volume><fpage>288</fpage><lpage>306</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Yoon</surname><given-names>S</given-names></name><name><surname>Moon</surname><given-names>JO</given-names></name></person-group><article-title>The flavonoid naringin inhibits dimethylnitrosamine-induced liver damage in rats</article-title><source>Biol Pharm Bull</source><year>2004</year><volume>27</volume><fpage>72</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">14709902</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Chander</surname><given-names>V</given-names></name><name><surname>Chopra</surname><given-names>K</given-names></name></person-group><article-title>Protective effect of naringin, a bioflavonoid on ferric nitrilotriacetate-induced oxidative renal damage in rat kidney</article-title><source>Toxicology</source><year>2004</year><volume>201</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15297014</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><etal/></person-group><article-title>Butenolide induced cytotoxicity by disturbing the prooxidant&#x02013;antioxidant balance, and antioxidants partly quench in human chondrocytes</article-title><source>Toxico <italic>in Vitro</italic></source><year>2009</year><volume>23</volume><fpage>99</fpage><lpage>104</lpage></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skretkowicz</surname><given-names>J</given-names></name><name><surname>Sekulska</surname><given-names>M</given-names></name><name><surname>Danilewicz</surname><given-names>M</given-names></name><name><surname>Wagrowska-Danilewicz</surname><given-names>M</given-names></name><name><surname>Polakowski</surname><given-names>P</given-names></name></person-group><article-title>Effect of some anticancer drugs and combined chemotherapy on renal toxicity</article-title><source>Biol Signals</source><year>1996</year><volume>5</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">8739323</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Sayyad</surname><given-names>HI</given-names></name><name><surname>Ismail</surname><given-names>MF</given-names></name><name><surname>Shalaby</surname><given-names>FM</given-names></name><name><surname>Abou-El- Magd</surname><given-names>RF</given-names></name><name><surname>Gaur</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats</article-title><source>Int J Sci</source><year>2009</year><volume>5</volume><fpage>466</fpage><lpage>473</lpage></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulcin</surname><given-names>I</given-names></name><name><surname>Berashvili</surname><given-names>D</given-names></name><name><surname>Gepdiremen</surname><given-names>A</given-names></name></person-group><article-title>Antiradical and antioxidant activity of total anthocyanins from Perilla pankinensis decne</article-title><source>J Ethnopharmacol</source><year>2005</year><volume>101</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">15964162</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polidoro</surname><given-names>G</given-names></name><name><surname>Dillio</surname><given-names>C</given-names></name><name><surname>La Rovere</surname><given-names>G</given-names></name><name><surname>Fedrici</surname><given-names>GS</given-names></name></person-group><article-title>Superoxide dismutase, reduced glutathione and TBA-reactive products in erythrocytes of patients with multiple sclerosis</article-title><source>Int J Biochem</source><year>1984</year><volume>16</volume><fpage>505</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">6724105</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polat K&#x000f6;se</surname><given-names>L</given-names></name><name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>I</given-names></name><name><surname>G&#x000f6;ren</surname><given-names>AC</given-names></name><name><surname>Namiesnik</surname><given-names>J</given-names></name><name><surname>Martinez-Ayala</surname><given-names>AL</given-names></name><name><surname>Gorinstein</surname><given-names>S</given-names></name></person-group><article-title>LC-MS/MS analysis, antioxidant and anticholinergic properties of galanga (Alpinia officinarum Hance) rhizomes</article-title><source>Ind Crops Prod</source><year>2015</year><volume>74</volume><fpage>712</fpage><lpage>721</lpage></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulcin</surname><given-names>I</given-names></name><name><surname>Beydemir</surname><given-names>S</given-names></name></person-group><article-title>Phenolic compounds as antioxidants: Carbonic anhydrase isoenzymes inhibitors</article-title><source>Mini Rev Med Chem</source><year>2013</year><volume>13</volume><fpage>408</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">23190033</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sehitoglu</surname><given-names>MH</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Kalin</surname><given-names>P</given-names></name><name><surname>Gulcin</surname><given-names>I</given-names></name><name><surname>Ozkan</surname><given-names>A</given-names></name><name><surname>Aboul-Enein</surname><given-names>HY</given-names></name><etal/></person-group><article-title>Gum A potent inhibitor of reactive oxygen specie</article-title><source>J Enzym Inhib Med Chem</source><year>2015</year><volume>30</volume><fpage>264</fpage><lpage>269</lpage></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Namiesnik</surname><given-names>J</given-names></name><name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>I</given-names></name><name><surname>Kim</surname><given-names>TC</given-names></name><name><surname>Kim</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Effects of artificial lighting on bioactivity of sweet red pepper (Capsicum annuum L.)</article-title><source>Int J Food Sci Technol</source><year>2016</year><volume>51</volume><fpage>1378</fpage><lpage>1385</lpage></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Panichpisal</surname><given-names>K</given-names></name><name><surname>Kurtzman</surname><given-names>N</given-names></name><name><surname>Nugent</surname><given-names>K</given-names></name></person-group><article-title>Cisplatin nephrotoxicity, A review</article-title><source>Am J Med Sci</source><year>2007</year><volume>334</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">17700201</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Ge</surname><given-names>X</given-names></name><etal/></person-group><article-title>Selective bowel decontamination improves the survival of 90% hepatectomy in rats</article-title><source>J Surg Res</source><year>2015</year><volume>195</volume><fpage>454</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">25770738</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alwahsh</surname><given-names>SM</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Seyhan</surname><given-names>SA</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Mihm</surname><given-names>S</given-names></name><name><surname>Ramadori</surname><given-names>G</given-names></name><etal/></person-group><article-title>Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty live</article-title><source>World J Gastroenterol</source><year>2014</year><volume>20</volume><fpage>1807</fpage><lpage>1821</lpage><pub-id pub-id-type="pmid">24587658</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godos</surname><given-names>J</given-names></name><name><surname>Federico</surname><given-names>A</given-names></name><name><surname>Dallio</surname><given-names>M</given-names></name><name><surname>Scazzina</surname><given-names>F</given-names></name></person-group><article-title>Mediterranean diet and nonalcoholic fatty liver disease: Molecular mechanisms of protection</article-title><source>Int J Food Sci Nutr</source><year>2017</year><volume>68</volume><fpage>18</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">27484357</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulcin</surname><given-names>I</given-names></name></person-group><article-title>Antioxidant and antiradical activities of L-Carnitine</article-title><source>Life Sci</source><year>2006</year><volume>78</volume><fpage>803</fpage><lpage>811</lpage><pub-id pub-id-type="pmid">16253281</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buyukokuroglu</surname><given-names>ME</given-names></name><name><surname>Gulcin</surname><given-names>I</given-names></name><name><surname>Oktay</surname><given-names>M</given-names></name><name><surname>Kufrevioglu</surname><given-names>O</given-names></name></person-group><article-title>In vitro antioxidant properties of dantrolene sodium</article-title><source>Pharmacol Res</source><year>2001</year><volume>44</volume><fpage>491</fpage><lpage>494</lpage><pub-id pub-id-type="pmid">11735355</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulcin</surname><given-names>I</given-names></name><name><surname>Buyukokuroglu</surname><given-names>ME</given-names></name><name><surname>Oktay</surname><given-names>M</given-names></name><name><surname>Kufrevioglu</surname><given-names>OI</given-names></name></person-group><article-title><italic>In vitro</italic> antioxidant properties of dantrolene sodium. Antioxidant and analgesic activities of turpentine of <italic>Pinus nigra</italic> Arn. Subsp. pallsiana (Lamb.) Holmboe</article-title><source>J Ethnopharmacol</source><year>2003</year><volume>86</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">12686441</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nora El-Hoseany</surname><given-names>MA</given-names></name></person-group><article-title>Protective Effect of Captopril against 5-Fluorouracil-Induced Hepato and Nephrotoxicity in Male Albino Rats</article-title><source>J American Sci</source><year>2012</year><volume>8</volume><fpage>680</fpage><lpage>685</lpage></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afolabi</surname><given-names>OK</given-names></name><name><surname>Adelek e1</surname><given-names>GE</given-names></name><name><surname>Ugbaja</surname><given-names>RN</given-names></name></person-group><article-title>Crocin Alleviates 5-Fluorouracil-induced Hepatotoxicity through the abrogation of Oxidative Stress in Male Wistar rats</article-title><source>Asian Pac J Health Sci</source><year>2016</year><volume>3</volume><fpage>58</fpage><lpage>68</lpage></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimitriu</surname><given-names>D</given-names></name><name><surname>Lupusoru</surname><given-names>C</given-names></name><name><surname>Cojocaru</surname><given-names>I</given-names></name><name><surname>Gafitanu</surname><given-names>C</given-names></name><name><surname>Palade</surname><given-names>L</given-names></name><name><surname>Lupusoru</surname><given-names>R</given-names></name></person-group><article-title>Assessing biochemical andoxidative stress parameters after vaginal and oral administration of 5-fluorouracil in laboratory animals</article-title><source>Farmacia</source><year>2015</year><volume>63</volume><fpage>230</fpage><lpage>233</lpage></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stockham</surname><given-names>SL</given-names></name><name><surname>Scott</surname><given-names>MA</given-names></name></person-group><source>Fundamentals of Veterinary Clinical Pathology</source><year>2002</year><volume>52</volume><publisher-loc>Ames, Iowa</publisher-loc><publisher-name>State University Press</publisher-name><fpage>434</fpage><lpage>459</lpage></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeashan</surname><given-names>H</given-names></name><name><surname>Amresh</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Rao</surname><given-names>CV</given-names></name></person-group><article-title>Hepatoprotective and antioxidant activity of Amaranthus spinosus against CCl4 induced toxicity</article-title><source>J Ethnopharmacol</source><year>2009</year><volume>125</volume><fpage>364</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">19465104</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacNamara</surname><given-names>E</given-names></name><name><surname>Goldberg</surname><given-names>DM</given-names></name></person-group><article-title>Serum enzymes and enzyme profiles in the diagnosis of liver and biliary tract diseas</article-title><source>Surv Dig Dis</source><year>1985</year><volume>3</volume><fpage>165</fpage><lpage>186</lpage></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nada</surname><given-names>O</given-names></name></person-group><article-title>A review of propolis antitumour action <italic>in vivo</italic> and <italic>in vitro</italic></article-title><source>J Api Product Api Med Sci</source><year>2010</year><volume>2</volume><fpage>1</fpage><lpage>20</lpage></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laverty</surname><given-names>HG</given-names></name><name><surname>Antoine</surname><given-names>DJ</given-names></name><name><surname>Benson</surname><given-names>C</given-names></name><name><surname>Chaponda</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>BK</given-names></name></person-group><article-title>The potential of cytokines as safety biomarkers for drug-induced liver injury</article-title><source>Eur J Clin Pharmacol</source><year>2010</year><volume>66</volume><fpage>961</fpage><lpage>976</lpage><pub-id pub-id-type="pmid">20694460</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacour</surname><given-names>S</given-names></name><name><surname>Gautier</surname><given-names>JC</given-names></name><name><surname>Pallardy</surname><given-names>M</given-names></name><name><surname>Roberts</surname><given-names>R</given-names></name></person-group><article-title>Cytokines as potential biomarkers of liver toxicity</article-title><source>Cancer Biomarkers</source><year>2005</year><volume>1</volume><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">17192030</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CT</given-names></name><name><surname>Ho</surname><given-names>TY</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Liang</surname><given-names>JA</given-names></name><name><surname>Huang</surname><given-names>HC</given-names></name></person-group><article-title>5-Fluorouracil induced intestinal mucositis via nuclear factor-kB activation by transcriptomic analysis and <italic>in vivo</italic> bioluminescence imaging</article-title><source>PLoS ONE</source><year>2017</year><volume>7</volume><fpage>e31808</fpage></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peluso</surname><given-names>I</given-names></name><name><surname>Raguzzini</surname><given-names>A</given-names></name><name><surname>Serafini</surname><given-names>M</given-names></name></person-group><article-title>Effect of flavonoids on circulating levels of TNF-&#x003b1;and IL-6 in humans: a systematic review and meta-analysis</article-title><source>Mol Nutr Food</source><year>2015</year><volume>57</volume><fpage>784</fpage><lpage>801</lpage></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinho-Ribeiro</surname><given-names>FA</given-names></name><name><surname>Zarpelon</surname><given-names>AC</given-names></name><name><surname>Mizokami</surname><given-names>SS</given-names></name><name><surname>Borghi</surname><given-names>SM</given-names></name><name><surname>Bordignon</surname><given-names>J</given-names></name><name><surname>Silva</surname><given-names>RL</given-names></name><etal/></person-group><article-title>The citrus flavonone naringin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-&#x003ba;B activation</article-title><source>J Nutr Biochem</source><year>2016</year><volume>33</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">27260463</pub-id></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hak</surname><given-names>Heba</given-names></name><name><surname>Nageh Gad</surname><given-names>EL</given-names></name><name><surname>Tarek Ibrahim Saad</surname><given-names>M</given-names></name><name><surname>Gamal Abdel</surname><given-names>A</given-names></name></person-group><article-title>&#x0201c;Histological study of the effect of chemotherapy with 5-Fluorouracil on normal liver and kidney of mice</article-title><source>International J Novel Res Life Sci</source><year>2015</year><volume>2</volume><fpage>8</fpage><lpage>13</lpage></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadet</surname><given-names>J</given-names></name><name><surname>Douki</surname><given-names>T</given-names></name><name><surname>Gasparutto</surname><given-names>D</given-names></name><name><surname>Ravanat</surname><given-names>JL</given-names></name></person-group><article-title>Oxidative damage to DNA: formation, measurement and biochemical features</article-title><source>Mutat Res Fund Mol M</source><year>2003</year><volume>531</volume><fpage>5</fpage><lpage>23</lpage></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stepniak</surname><given-names>J</given-names></name><name><surname>Karbownik-Lewinska</surname><given-names>M</given-names></name></person-group><article-title>17 &#x003b2;-estradiol prevents experimentally-induced oxidative damage to membrane lipids and nuclear DNA in porcine ovary</article-title><source>Sys Biol Reprod Med</source><year>2016</year><volume>62</volume><fpage>17</fpage><lpage>21</lpage></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadet</surname><given-names>J</given-names></name></person-group><article-title>Oxidative degradation pathways of cellular DNA: product formation and mechanistic insights</article-title><source>Free Radical Biol Med</source><year>2016</year><volume>75</volume><fpage>S2</fpage></element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Sayyad</surname><given-names>IH</given-names></name><name><surname>Hassan</surname><given-names>A</given-names></name></person-group><article-title>Effects of adriamycin, cisplatin, and 5-fluorouracil on the testes of albino rats</article-title><source>Br J Med Health Sci</source><year>2013</year><volume>1</volume><fpage>45</fpage><lpage>62</lpage></element-citation></ref><ref id="ref49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ince</surname><given-names>S</given-names></name><name><surname>Arslan Acaroz</surname><given-names>D</given-names></name><name><surname>Neuwirth</surname><given-names>O</given-names></name><name><surname>Hasan H&#x000fc;seyin</surname><given-names>D</given-names></name><name><surname>Bar&#x00131;s</surname><given-names>D</given-names></name><name><surname>&#x00130;smail</surname><given-names>K</given-names></name><etal/></person-group><article-title>Protective effect of polydatin, a natural precursor of resveratrol, against cisplatininduced toxicity in rats</article-title><source>Food Chem Toxicol</source><year>2014</year><volume>72</volume><fpage>147</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">25051394</pub-id></element-citation></ref></ref-list></back></article>